This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Sandra Rojas-Caro: Innovator in Mucopolysaccharidosis Treatment
Introduction
Sandra Rojas-Caro is a prominent inventor based in Waltham, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of mucopolysaccharidosis IIIB (MPSIIIB). Her innovative approach has the potential to improve the lives of patients suffering from this rare genetic disorder.
Latest Patents
Sandra holds a patent for "Methods of treating Mucopolysaccharidosis IIIB (MPSIIIB)." This patent outlines methods for treating the central nervous system (CNS) in human patients with MPS who have an intact blood-brain barrier. The treatment involves the intravenous administration of recombinant NaGlu. This groundbreaking work has led to her recognition as an influential figure in her field, with 1 patent to her name.
Career Highlights
Sandra is currently employed at Alexion Pharmaceuticals, Inc., where she continues to develop innovative treatments for rare diseases. Her work at Alexion has positioned her at the forefront of research and development in the pharmaceutical industry.
Collaborations
Throughout her career, Sandra has collaborated with notable colleagues, including Anthony Quinn and Anthony Rossomando. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Sandra Rojas-Caro is a dedicated inventor whose work in the treatment of mucopolysaccharidosis IIIB is paving the way for advancements in medical science. Her contributions are vital to improving patient outcomes and advancing the field of rare disease treatment.